OJJAARA

Identification of Ojjaara

No description

Google image searchProduct monograph

Active ingredient

momelotinib (momelotinib dihydrochloride), 100 MG

DIN: 02552965

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 21-JAN-2025

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EJ — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L01EJ04 — MOMELOTINIB (ATC/DDD)

Reference brand drug: Ojjaara

External Links for Ojjaara

Search on Google

• Ojjaara side effects
• Ojjaara dosage
• momelotinib side effects
• momelotinib dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find ojjaara photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.